DexCom Inc. has provided its initial financial outlook for 2026, projecting total revenue in the range of $5.16 to $5.25 billion, which represents an expected growth of approximately 11-13% over 2025. This forecast follows preliminary, unaudited 2025 fiscal year revenue of approximately $4.662 billion, a 16% increase from the previous year, with fourth quarter revenue reaching about $1.260 billion, up 13% from the same period in 2024. For 2026, the company anticipates a non-GAAP gross profit margin of approximately 63-64% and a non-GAAP operating margin of about 22-23%, both reflecting an improvement over 2025 guidance. DexCom attributes the continued growth to increasing adoption of its CGM technologies, the ongoing rollout of new products, and further international expansion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DexCom Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260112293861) on January 12, 2026, and is solely responsible for the information contained therein.